US FDA Approves At-Home Use of Drug for Schizophrenia, Bipolar-Related Agitation
ISLAMABAD: (Web Desk) The US Food and Drug Administration (FDA) has approved the at-home use of Igalmi, a medication designed to treat agitation associated with schizophrenia and bipolar disorder, expanding its availability beyond…